DataMeds AI, Inc. (MEDS)
2.90
-0.17
(-5.54%)
USD |
NASDAQ |
Oct 07, 16:00
2.86
-0.04
(-1.38%)
After-Hours: 17:21
DataMeds AI Free Cash Flow : -14.66M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.66M |
| March 31, 2026 | -13.73M |
| December 31, 2025 | -11.74M |
| September 30, 2025 | -8.045M |
| June 30, 2025 | -5.580M |
| March 31, 2025 | -3.339M |
| Date | Value |
|---|---|
| December 31, 2024 | -1.687M |
| September 30, 2024 | 0.7078M |
| June 30, 2024 | -0.2879M |
| March 31, 2024 | -0.3179M |
| December 31, 2023 | -0.3491M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.1401M |
| Stella Diagnostics, Inc. | -2.365M |
| Interpace Biosciences, Inc. | 4.104M |
| Medical Marijuana, Inc. | -0.3957M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.894M |
| Cash from Investing (Quarterly) | -0.2421M |
| Cash from Financing (Quarterly) | 5.541M |
| Free Cash Flow Per Share (Quarterly) | -1.218 |
| Free Cash Flow to Equity (Quarterly) | -7.012M |
| Free Cash Flow to Firm (Quarterly) | -1.575M |
| Free Cash Flow Yield | -230.4% |